Jon Chapman
Vice President, Life Sciences


Industry
Life sciences organizations are under pressure to accelerate clinical development, operationalize AI, and offset revenue loss from patent cliffs, all while managing increasing regulatory complexity and rising R&D costs.
We help reduce delays across clinical development, regulatory operations, manufacturing, and commercialization by connecting how work, data, and decisions move across the enterprise. The result is faster study execution, stronger operational visibility, and more scalable performance from development through launch.


Organizations face loss of exclusivity pressure while managing complex global pipelines across development, regulatory, manufacturing, and commercial teams. We help improve governance, cross-functional workflows, and visibility to accelerate launches and bring therapies to market faster.
Emerging biotech companies must scale clinical operations, regulatory capabilities, and commercialization readiness with limited resources and funding. We help build the workflows, governance, and data foundations needed to improve execution, stay lean, and support growth.
Tech organizations operate in highly regulated environments where product innovation, quality, and compliance must move in sync. We help modernize operations, connect data and workflows, and improve coordination from development through commercialization.
Organizations operate in complex partner ecosystems where coordination, visibility, and speed drive delivery. We help connect sponsor, CRO, and manufacturing workflows to reduce delays, improve reliability, and strengthen compliance across the value chain.

A global life sciences organization relied on manual process mapping across clinical operations, slowing trial execution and limiting visibility across the study lifecycle. They needed a scalable way to standardize workflows and accelerate improvement across clinical development.
See how Point B helped operationalize GenAI within clinical workflows, reducing process drafting time by 70% and enabling 3x faster delivery.

We help life sciences organizations reduce delays across clinical development, regulatory operations, manufacturing, and commercialization by redesigning workflows, clarifying decision ownership, and improving coordination across teams and systems. The result is faster study execution, lower operational friction, and more predictable performance across the enterprise.
This work includes:

We help life sciences organizations operationalize AI and improve decision-making by connecting clinical, regulatory, manufacturing, and commercial data across the enterprise. By embedding AI into real workflows and modernizing fragmented platforms, we help organizations move beyond pilots and scale more reliable, data-driven performance.
This work includes:
Meet the experts trusted to bring organizations together around common goals. They're here to help you bridge gaps between technologies, partners, people, and systems.